{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-050682","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2023-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.940966+00:00","generated_at":"2026-06-09T03:33:45.524737+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Dr. James Bristol appointed to board of Eterna Therapeutics","bullets":["Dr. James Bristol appointed as director effective Oct 30, 2023; term until 2024 annual meeting.","Bristol appointed to Audit, Compensation, and Nominating/Corporate Governance Committees.","Board determined Bristol is independent under Nasdaq rules; no material transactions with the Company.","Standard non-employee director compensation and indemnification agreement to be entered into."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-050682","json":"https://secwatch.observer/filing/0001140361-23-050682.json","markdown":"https://secwatch.observer/filing/0001140361-23-050682.md","text":"https://secwatch.observer/filing/0001140361-23-050682.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036123050682/0001140361-23-050682-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036123050682/ef20013697_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T03:33:45.524737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3971a1a01a","claim":"Dr. James Bristol was appointed as director at Ernexa Therapeutics Inc..","evidence_excerpt":"On October 30, 2023, the Board of Directors (the “Board”) of Eterna Therapeutics Inc. (the “Company”) appointed Dr. James Bristol as a director, effective on October 30, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/748592/000114036123050682/0001140361-23-050682-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}